Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00188
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

CXCR4/CXCL12 Axis Promotes VEGF-mediated Tumor Angiogenesis Through Akt Signaling Pathway

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2007English

The CXCL12-CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis

Clinical Cancer Research
Cancer ResearchOncology
2012English

CXCR4 Up-Regulation by Imatinib Induces Chronic Myelogenous Leukemia (CML) Cell Migration to Bone Marrow Stroma and Promotes Survival of Quiescent CML Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Adipocytes Enhance Expression of Osteoclast Adhesion-Related Molecules Through the CXCL12/CXCR4 Signalling Pathway

Cell Proliferation
MedicineCell Biology
2016English

Galectin-3 Mediates Bone Marrow Microenvironment-Induced Drug Resistance in Acute Leukemia Cells via WNT/Β-Catenin Signaling Pathway

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2015English

Notch1 Signaling Pathway Promotes Invasion, Self-Renewal and Growth of Glioma Initiating Cells via Modulating Chemokine System CXCL12/CXCR4

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Active mTORC2 Signaling in Naive T Cells Suppresses Bone Marrow Homing by Inhibiting CXCR4 Expression

Journal of Immunology
AllergyImmunology
2018English

Oroxylin a Inhibits Ethanol-Induced Hepatocyte Senescence via YAP Pathway

Cell Proliferation
MedicineCell Biology
2018English

Peptides and Small Molecules Blocking the CXCR4/CXCL12 Axis Overcome Bone Marrow‑induced Chemoresistance in Acute Leukemias

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy